Dr. Millenson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3941 Commerce Ave
Willow Grove, PA 19090Phone+1 215-481-2400- Is this information wrong?
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, 1988 - 1991
- Temple University HospitalResidency, 1984 - 1987
- Lewis Katz School of Medicine at Temple UniversityClass of 1984
Certifications & Licensure
- PA State Medical License 1985 - 2024
- NJ State Medical License 1988 - 1991
- NC State Medical License 1987 - 1988
- ME State Medical License Active through 1988
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 37 citationsVoxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trialJennifer R. Brown, Mehdi Hamadani, John Hayslip, Ann Janssens, Nina D. Wagner-Johnston, Oliver G. Ottmann, Jon E. Arnason, Hervé Tilly, Michael Millenson, Fritz Offner...> ;The Lancet. Haematology. 2018 Apr 1
- 743 citationsNivolumab in patients with relapsed or refractory hematologic malignancy: Preliminary results of a phase ib study, , , , , , , , , , , , , , , , , , , , , > ;Journal of Clinical Oncology. 2016 Sep 27
- 11 citationsCopy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma.Jianming Pei, Valentin G. Robu, Madelyn Feder, Mitchell Cheung, Erin Neumann-Domer, Jacqueline Talarchek, Essel Dulaimi, Michael Millenson, Joseph R. Testa> ;Cancer Genetics. 2014 Mar 1
Hospital Affiliations
- Jefferson Abington HealthAbington, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: